Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PfSPZ Challenge intradermal dose-finding malaria challenge study
NL-OMON35056Active, not recruiting
- Sponsor
- Sanaria Inc.
- Start
- Oct 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of PfSPZ Challenge in malaria (3 cohorts), sponsored by Sanaria Inc. Primary endpoint: 100% thick smear positivity. Started Oct 2010; status: active, not recruiting.
02
Drugs
PfSPZ Challenge
03
Conditions
malaria
Beyond the preview
Go deeper on NL-OMON35056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35056.